💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @atwoodct | 10 |
| @FlashAlert_me | 5 |
| @ShortAlgoTrades | 5 |
| @Tickeron | 5 |
| @investor_feed | 4 |
Recent Tweets for ESPR
 |
@CSIMarket $ESPR #StockMarket #EsperionTherapeutics published most recent fiscal period Revenues on https://t.co/savSNTKlN1: E… https://t.co/pvIbEjFhCc 3:08am |
 |
@GaryRizk $ESPR @EsperionInc Dr. Nissen talks about the BA Clear Outcomes Trial at the 9:30 minute mark. @hillypaige2… https://t.co/RMsIqTyc02 3:08am |
 |
@StckPro $ESPR NEW ARTICLE : Esperion: Hunting Big Game In The Danger Zone https://t.co/vXv99CYMV2 Get all the latest $ESPR… https://t.co/AqptiLRFOb 2:08am |
 |
@SeekingAlpha $ESPR - Esperion: Hunting Big Game In The Danger Zone. https://t.co/l2QXrdl2zh #economy #stocks #investing 1:08am |
 |
@ShortAlgoTrades $ESPR And now, patiently waiting for a buy signal. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/7OAoQn2D90 August 4th 2021, 10:08pm |
 |
@puck_flastic The asswipes at $espr r almost out of of biz and they had the audacity to file a mixed shelf offering? Can someone… https://t.co/7wude48kIJ August 4th 2021, 9:08pm |
 |
@John_galt1111 $ESPR bottom curl phoenix ?? August 4th 2021, 3:08pm |
 |
@OptionHunt Ticker $ESPR Unusual Volume Detected: 50.22% over average August 4th 2021, 2:08pm |
 |
@Jarvis_Alerts $ESPR [Esperion Therapeutics]: Morgan Stanley Maintains Equal-Weight Lowers Price Target $22 --> 17 charts: courte… https://t.co/Kf6g5L2olA August 4th 2021, 2:08pm |
|
@ShortAlgoTrades $ESPR Awaiting Buy Signal with the UltraAlgo on ESPR . https://t.co/FbXAdMcewK August 4th 2021, 10:08am |
 |
@EarningsAlley Esperion Therapeutics, Inc. $ESPR held an earnings call on 8/3/2021. Here are the highlights: August 4th 2021, 12:08am |
 |
@vimarblanco $ESPR Awaiting for Buy signal on ESPR . https://t.co/tkiHL4fk7c August 3rd 2021, 11:08pm |
 |
@skaushi @sunrgu And we are waiting for $ESPR to be taken out. So much for statin intolerance ???? August 3rd 2021, 6:08pm |
 |
@SiteFocusHQ $ESPR Earnings Intelligence Analysis of recent earnings identified ESPR business focus on (nexletol,nexlizet,prescr… https://t.co/wvBF3lC3tw August 3rd 2021, 6:08pm |
 |
@BH1377 I'll let others discuss the short squeeze potential, but there's a FUNDAMENTAL INVESTMENT case for $ESPR . The pote… https://t.co/7eoWajEjsp August 3rd 2021, 5:08pm |
|
@SeekingAlpha $ESPR - Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results - Earnings Call Transcript.… https://t.co/XDQ1vV2YcI August 3rd 2021, 4:08pm |
|
@atwoodct $espr. I read this will do 5 billion in revenue and be 300 pps soon. Anyone else read that? August 3rd 2021, 4:08pm |
|
@Asker753 $ESPR is a good report, better than last quarter, you need to buy it. August 3rd 2021, 4:08pm |
|
@Asker753 $ESPR, now only up!??? August 3rd 2021, 4:08pm |
 |
@mcguigas RT @Jarvis_Alerts: $ESPR [Esperion Therapeutics]: Needham Maintains Strong Buy Lowers Price Target $134 --> 114 charts: courtesy of finviz… August 3rd 2021, 4:08pm |
|
@Jarvis_Alerts $ESPR [Esperion Therapeutics]: Needham Maintains Strong Buy Lowers Price Target $134 --> 114 charts: courtesy of f… https://t.co/RxM5cuknZE August 3rd 2021, 4:08pm |
 |
@DeepSouthDoctor (Deleted incorrect tweet). $ESPR: Gets my vote for best example of a legit biotech that (consistently) has consis… https://t.co/5DmKIj1wbg August 3rd 2021, 3:08pm |
 |
@quantisnow $ESPR ? Needham reiterated coverage on Esperion Therapeutics with a new price target https://t.co/S0sM1qQozY 30s delayed. August 3rd 2021, 3:08pm |
|
@John_galt1111 $ESPR: Esperion Therapeutics files mixed securities shelf offering August 3rd 2021, 3:08pm |
 |
@Briefingcom $ESPR: Esperion Therapeutics files mixed securities shelf offering https://t.co/cUroso9Bdf August 3rd 2021, 3:08pm |
 |
@SmallCapsDaily $ESPR ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update GlobeNewswire… https://t.co/N3plX1M9bg August 3rd 2021, 3:08pm |
 |
@BioWino RT @sbwcws: Esperion files $250M mixed securities shelf $ESPR August 3rd 2021, 3:08pm |
 |
@sbwcws Esperion files $250M mixed securities shelf $ESPR August 3rd 2021, 3:08pm |
 |
@MarketNFlash Esperion Therapeutics S-3 Shows Registration For $250M Mixed Securities Shelf Offering | $ESPR August 3rd 2021, 3:08pm |
 |
@newsfilterio Form RW (registration withdrawal request) filed with the SEC $ESPR https://t.co/cajKN28d1R August 3rd 2021, 3:08pm |
 |
@FlashAlert_me $ESPR [15s. delayed] filed form S-3ASR on August 03, 11:05:47 https://t.co/LB140uumDE August 3rd 2021, 3:08pm |
 |
@fintel_io $ESPR / Esperion Therapeutics files form RW https://t.co/IwLSIXeG7y August 3rd 2021, 3:08pm |
 |
@investor_feed $ESPR RW Esperion Therapeutics (3 Aug, 11:04am) ? Registration withdrawal request https://t.co/tnAl2RNsIG… https://t.co/d3kv0ypyHp August 3rd 2021, 3:08pm |
|
@FlashAlert_me $ESPR [15s. delayed] filed form RW on August 03, 11:04:31 https://t.co/JM9jMRg3h2 August 3rd 2021, 3:08pm |
|
@SeekingAlpha $ESPR - Esperion Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation. https://t.co/KfQpva1kFo #stocks #trading #economy August 3rd 2021, 2:08pm |
 |
@AlertTrade UP WITH EARNINGS: $ESPR Esperion Therapeutics, Inc https://t.co/Rg2Bu7vfDI ? TradeIdeas via ? https://t.co/VS8RO1bzXJ August 3rd 2021, 2:08pm |
 |
@LargeVoidBot 09:36 New 52wk Lows: $ESPR August 3rd 2021, 1:08pm |
|
@MarketNFlash Esperion Therapeutics Files For Potential Mixed Shelf Offering | $ESPR August 3rd 2021, 1:08pm |
|
@fintel_io $ESPR / Esperion Therapeutics files form S-3 https://t.co/IwLSIXeG7y August 3rd 2021, 1:08pm |
|
@FlashAlert_me $ESPR [15s. delayed] filed form S-3 on August 03, 09:27:03 https://t.co/mazIvgCJ2y August 3rd 2021, 1:08pm |
|
@investor_feed $ESPR S-3 Esperion Therapeutics (3 Aug, 9:27am) ? Shelf registration https://t.co/0A4oIzc7QV #ESPR #S3 #EsperionTherapeutics August 3rd 2021, 1:08pm |
|
@Briefingcom $ESPR: Esperion Therapeutics beats by $0.18, misses on revs https://t.co/5sG3GDqn6T August 3rd 2021, 1:08pm |
 |
@EdgarInsider SEC Form 10-Q [Quarterly Report] filed by $ESPR #EsperionTherapeutics, Inc. #EsperionTherapeutics, Inc https://t.co/j7nFxXXGHU August 3rd 2021, 12:08pm |
|
@investor_feed $ESPR 10-Q Esperion Therapeutics (3 Aug, 8:56am) ? 2021 Q2 Earnings https://t.co/fSin8IsaTa #ESPR #10Q… https://t.co/mRPcijPhmP August 3rd 2021, 12:08pm |
|
@FlashAlert_me $ESPR [15s. delayed] filed form 10-Q on August 03, 08:56:16 https://t.co/R1ISuA3Uzm August 3rd 2021, 12:08pm |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in ESPERION THERAPEUTICS INC. CO $ESPR https://t.co/9lEUQRfr3O August 3rd 2021, 12:08pm |
 |
@otcdynamics $ESPR ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update https://t.co/jTEAulurQj August 3rd 2021, 11:08am |
 |
@StockPods $ESPR Earnings Call Today: 8:00 AM EST Webcast: https://t.co/ODHRclmqJV Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 August 3rd 2021, 11:08am |
|
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $ESPR #EsperionTherapeutics, Inc.… https://t.co/lGzgx8Os0F August 3rd 2021, 11:08am |
 |
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 180 August 3rd 2021, 11:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?